{"id":"https://openalex.org/W2013601409","doi":"https://doi.org/10.1002/cmdc.200900249","title":"Design and Synthesis of a Series of Piperazine\u20101\u2010carboxamidine Derivatives with Antifungal Activity Resulting from Accumulation of Endogenous Reactive Oxygen Species","display_name":"Design and Synthesis of a Series of Piperazine\u20101\u2010carboxamidine Derivatives with Antifungal Activity Resulting from Accumulation of Endogenous Reactive Oxygen Species","publication_year":2009,"publication_date":"2009-08-24","ids":{"openalex":"https://openalex.org/W2013601409","doi":"https://doi.org/10.1002/cmdc.200900249","mag":"2013601409","pmid":"https://pubmed.ncbi.nlm.nih.gov/19705386"},"language":"en","primary_location":{"id":"doi:10.1002/cmdc.200900249","doi":"https://doi.org/10.1002/cmdc.200900249","is_oa":false,"landing_page_url":"https://doi.org/10.1002/cmdc.200900249","pdf_url":null,"source":{"id":"https://openalex.org/S136164820","display_name":"ChemMedChem","issn_l":"1860-7179","issn":["1860-7179","1860-7187"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ChemMedChem","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056106599","display_name":"Isabelle Fran\u00e7ois","orcid":"https://orcid.org/0009-0000-6477-9744","observed_orcids":["https://orcid.org/0009-0000-6477-9744"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Isabelle\u2005E. Fran\u00e7ois","raw_affiliation_strings":["Centre of Microbial and Plant Genetics, Katholieke Universiteit Leuven, Kasteelpark Arenberg 20, 3001 Heverlee (Belgium)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre of Microbial and Plant Genetics, Katholieke Universiteit Leuven, Kasteelpark Arenberg 20, 3001 Heverlee (Belgium)","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035853200","display_name":"Karin Thevissen","orcid":"https://orcid.org/0000-0003-0275-9072","observed_orcids":["https://orcid.org/0000-0003-0275-9072"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":true,"raw_author_name":"Karin Thevissen","raw_affiliation_strings":["Centre of Microbial and Plant Genetics, Katholieke Universiteit Leuven, Kasteelpark Arenberg 20, 3001 Heverlee (Belgium),"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre of Microbial and Plant Genetics, Katholieke Universiteit Leuven, Kasteelpark Arenberg 20, 3001 Heverlee (Belgium),","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003998241","display_name":"Klaartje Pellens","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Klaartje Pellens","raw_affiliation_strings":["Centre of Microbial and Plant Genetics, Katholieke Universiteit Leuven, Kasteelpark Arenberg 20, 3001 Heverlee (Belgium),"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre of Microbial and Plant Genetics, Katholieke Universiteit Leuven, Kasteelpark Arenberg 20, 3001 Heverlee (Belgium),","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039729880","display_name":"Els M.K. Meert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Els\u2005M. Meert","raw_affiliation_strings":["Centre of Microbial and Plant Genetics, Katholieke Universiteit Leuven, Kasteelpark Arenberg 20, 3001 Heverlee (Belgium),"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre of Microbial and Plant Genetics, Katholieke Universiteit Leuven, Kasteelpark Arenberg 20, 3001 Heverlee (Belgium),","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046188438","display_name":"Jan Heeres","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Jan Heeres","raw_affiliation_strings":["Centre for Molecular Design, Janssen Pharmaceutica N.V. Antwerpsesteenweg 37, 2350 Vosselaar (Belgium)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Molecular Design, Janssen Pharmaceutica N.V. Antwerpsesteenweg 37, 2350 Vosselaar (Belgium)","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060008277","display_name":"Eddy J. E. Freyne","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Eddy Freyne","raw_affiliation_strings":["Johnson & Johnson Pharmaceutical Research & Development, Division of Janssen Pharmaceutica N.V., Turnhoutseweg 30, 2340 Beerse (Belgium)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johnson & Johnson Pharmaceutical Research & Development, Division of Janssen Pharmaceutica N.V., Turnhoutseweg 30, 2340 Beerse (Belgium)","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022551063","display_name":"Erwin Coesemans","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Erwin Coesemans","raw_affiliation_strings":["Johnson & Johnson Pharmaceutical Research & Development, Division of Janssen Pharmaceutica N.V., Turnhoutseweg 30, 2340 Beerse (Belgium)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johnson & Johnson Pharmaceutical Research & Development, Division of Janssen Pharmaceutica N.V., Turnhoutseweg 30, 2340 Beerse (Belgium)","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059325122","display_name":"Marcel Viellevoye","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Marcel Viellevoye","raw_affiliation_strings":["Johnson & Johnson Pharmaceutical Research & Development, Division of Janssen Pharmaceutica N.V., Turnhoutseweg 30, 2340 Beerse (Belgium)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johnson & Johnson Pharmaceutical Research & Development, Division of Janssen Pharmaceutica N.V., Turnhoutseweg 30, 2340 Beerse (Belgium)","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080993436","display_name":"Frederik D. Deroose","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Frederik Deroose","raw_affiliation_strings":["Johnson & Johnson Pharmaceutical Research & Development, Division of Janssen Pharmaceutica N.V., Turnhoutseweg 30, 2340 Beerse (Belgium)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johnson & Johnson Pharmaceutical Research & Development, Division of Janssen Pharmaceutica N.V., Turnhoutseweg 30, 2340 Beerse (Belgium)","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060108499","display_name":"Sonia Mart\u0131\u0301nez","orcid":"https://orcid.org/0000-0003-2230-7794","observed_orcids":["https://orcid.org/0000-0003-2230-7794"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sonia Martinez Gonzalez","raw_affiliation_strings":["Johnson & Johnson Pharmaceutical Research & Development, Division of Janssen-Cilag, C/ Jarama 75, Poligono Industrial, 45007 Toledo (Spain)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johnson & Johnson Pharmaceutical Research & Development, Division of Janssen-Cilag, C/ Jarama 75, Poligono Industrial, 45007 Toledo (Spain)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088584202","display_name":"Joaqu\u0131\u0301n Pastor","orcid":"https://orcid.org/0000-0003-0553-8021","observed_orcids":["https://orcid.org/0000-0003-0553-8021"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joaquin Pastor","raw_affiliation_strings":["Johnson & Johnson Pharmaceutical Research & Development, Division of Janssen-Cilag, C/ Jarama 75, Poligono Industrial, 45007 Toledo (Spain)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johnson & Johnson Pharmaceutical Research & Development, Division of Janssen-Cilag, C/ Jarama 75, Poligono Industrial, 45007 Toledo (Spain)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017584752","display_name":"David Corens","orcid":"https://orcid.org/0000-0002-9623-9299","observed_orcids":["https://orcid.org/0000-0002-9623-9299"]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"David Corens","raw_affiliation_strings":["Johnson & Johnson Pharmaceutical Research & Development, Division of Janssen Pharmaceutica N.V., Turnhoutseweg 30, 2340 Beerse (Belgium)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johnson & Johnson Pharmaceutical Research & Development, Division of Janssen Pharmaceutica N.V., Turnhoutseweg 30, 2340 Beerse (Belgium)","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056983974","display_name":"Lieven Meerpoel","orcid":"https://orcid.org/0000-0001-6370-0491","observed_orcids":["https://orcid.org/0000-0001-6370-0491"]},"institutions":[{"id":"https://openalex.org/I137982388","display_name":"Janssen (Belgium)","ror":"https://ror.org/04yzcpd71","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I137982388"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Lieven Meerpoel","raw_affiliation_strings":["Johnson & Johnson Pharmaceutical Research & Development, Division of Janssen Pharmaceutica N.V., Turnhoutseweg 30, 2340 Beerse (Belgium)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johnson & Johnson Pharmaceutical Research & Development, Division of Janssen Pharmaceutica N.V., Turnhoutseweg 30, 2340 Beerse (Belgium)","institution_ids":["https://openalex.org/I137982388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016519207","display_name":"\u039c. Borgers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I34352273","display_name":"Maastricht University","ror":"https://ror.org/02jz4aj89","country_code":"NL","type":"education","lineage":["https://openalex.org/I34352273"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Marcel Borgers","raw_affiliation_strings":["Barrier Therapeutics N.V., Cipalstraat 3, 2240 Geel (Belgium)","Department Molecular Cell Biology, CARIM, Maastricht University, Maastricht (The Netherlands)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barrier Therapeutics N.V., Cipalstraat 3, 2240 Geel (Belgium)","institution_ids":[]},{"raw_affiliation_string":"Department Molecular Cell Biology, CARIM, Maastricht University, Maastricht (The Netherlands)","institution_ids":["https://openalex.org/I34352273"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035779030","display_name":"Jannie Ausma","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jannie Ausma","raw_affiliation_strings":["Barrier Therapeutics N.V., Cipalstraat 3, 2240 Geel (Belgium)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barrier Therapeutics N.V., Cipalstraat 3, 2240 Geel (Belgium)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019403733","display_name":"G Dispersyn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gerrit\u2005D. Dispersyn","raw_affiliation_strings":["Barrier Therapeutics N.V., Cipalstraat 3, 2240 Geel (Belgium)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barrier Therapeutics N.V., Cipalstraat 3, 2240 Geel (Belgium)","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055040665","display_name":"Bruno P.A. Cammue","orcid":"https://orcid.org/0000-0001-8087-4768","observed_orcids":["https://orcid.org/0000-0001-8087-4768"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Bruno\u2005P. Cammue","raw_affiliation_strings":["Centre of Microbial and Plant Genetics, Katholieke Universiteit Leuven, Kasteelpark Arenberg 20, 3001 Heverlee (Belgium),"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre of Microbial and Plant Genetics, Katholieke Universiteit Leuven, Kasteelpark Arenberg 20, 3001 Heverlee (Belgium),","institution_ids":["https://openalex.org/I99464096"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5035853200"],"corresponding_institution_ids":["https://openalex.org/I99464096"],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":1.1572,"has_fulltext":false,"cited_by_count":19,"citation_normalized_percentile":{"value":0.77894042,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"4","issue":"10","first_page":"1714","last_page":"1721"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.4115999937057495,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.4115999937057495,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13160","display_name":"Synthesis and Biological Evaluation","score":0.21780000627040863,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.1809999942779541,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antifungal-agents","display_name":"antifungal agents","score":0.9359999895095825},{"id":"https://openalex.org/keywords/reactive-oxygen-species-accumulation","display_name":"reactive oxygen species accumulation","score":0.9179999828338623},{"id":"https://openalex.org/keywords/candida-albicans","display_name":"Candida albicans","score":0.9679999947547913},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.9169999957084656},{"id":"https://openalex.org/keywords/heterocycle-synthesis","display_name":"heterocyclic synthesis","score":0.5839999914169312},{"id":"https://openalex.org/keywords/compound-library-screening","display_name":"compound library screening","score":0.48899999260902405}],"concepts":[{"id":"https://openalex.org/C2776201271","wikidata":"https://www.wikidata.org/wiki/Q409292","display_name":"Piperazine","level":2,"score":0.9226374626159668},{"id":"https://openalex.org/C16613235","wikidata":"https://www.wikidata.org/wiki/Q285982","display_name":"Endogeny","level":2,"score":0.7441084980964661},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7173687219619751},{"id":"https://openalex.org/C48349386","wikidata":"https://www.wikidata.org/wiki/Q424361","display_name":"Reactive oxygen species","level":2,"score":0.705876350402832},{"id":"https://openalex.org/C74600772","wikidata":"https://www.wikidata.org/wiki/Q193237","display_name":"Fungicide","level":2,"score":0.5613692998886108},{"id":"https://openalex.org/C2780917455","wikidata":"https://www.wikidata.org/wiki/Q310443","display_name":"Candida albicans","level":2,"score":0.5510016679763794},{"id":"https://openalex.org/C540031477","wikidata":"https://www.wikidata.org/wiki/Q629","display_name":"Oxygen","level":2,"score":0.5298345685005188},{"id":"https://openalex.org/C2779548794","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal","level":2,"score":0.5167657136917114},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.35730206966400146},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.35429996252059937},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1747789978981018},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.14309611916542053},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.09222277998924255},{"id":"https://openalex.org/C59822182","wikidata":"https://www.wikidata.org/wiki/Q441","display_name":"Botany","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D002176","descriptor_name":"Candida albicans","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D002176","descriptor_name":"Candida albicans","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017382","descriptor_name":"Reactive Oxygen Species","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1002/cmdc.200900249","doi":"https://doi.org/10.1002/cmdc.200900249","is_oa":false,"landing_page_url":"https://doi.org/10.1002/cmdc.200900249","pdf_url":null,"source":{"id":"https://openalex.org/S136164820","display_name":"ChemMedChem","issn_l":"1860-7179","issn":["1860-7179","1860-7187"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ChemMedChem","raw_type":"journal-article"},{"id":"pmid:19705386","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19705386","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ChemMedChem","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.46810001134872437,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W105031452","https://openalex.org/W1804118339","https://openalex.org/W1972196027","https://openalex.org/W1980019714","https://openalex.org/W1983194079","https://openalex.org/W1984788848","https://openalex.org/W1992550492","https://openalex.org/W2021442034","https://openalex.org/W2029923992","https://openalex.org/W2041149058","https://openalex.org/W2045122657","https://openalex.org/W2053371306","https://openalex.org/W2057125151","https://openalex.org/W2062285888","https://openalex.org/W2081257374","https://openalex.org/W2094088518","https://openalex.org/W2094560110","https://openalex.org/W2095802468","https://openalex.org/W2100908752","https://openalex.org/W2101110341","https://openalex.org/W2105179604","https://openalex.org/W2107013040","https://openalex.org/W2107039058","https://openalex.org/W2107169184","https://openalex.org/W2121702473","https://openalex.org/W2126978003","https://openalex.org/W2128599767","https://openalex.org/W2140935709","https://openalex.org/W2141563676","https://openalex.org/W2145434920","https://openalex.org/W2150539008","https://openalex.org/W2157766752","https://openalex.org/W2952026402"],"related_works":["https://openalex.org/W1983277425","https://openalex.org/W2943015391","https://openalex.org/W3150463372","https://openalex.org/W3133437399","https://openalex.org/W4361191136","https://openalex.org/W2020980062","https://openalex.org/W2920286390","https://openalex.org/W7096797586","https://openalex.org/W4285612305","https://openalex.org/W6902342643"],"abstract_inverted_index":{"In":[0],"this":[1],"study,":[2],"we":[3,64],"screened":[4],"a":[5,50,59],"library":[6],"of":[7,15,70,72,79],"500":[8],"compounds":[9],"for":[10],"fungicidal":[11,61,68],"activity":[12],"via":[13],"induction":[14],"endogenous":[16,80],"reactive":[17],"oxygen":[18],"species":[19],"(ROS)":[20],"accumulation.":[21],"Structure-activity":[22],"relationship":[23],"studies":[24],"showed":[25],"that":[26],"piperazine-1-carboxamidine":[27,74],"analogues":[28],"with":[29],"large":[30,33],"atoms":[31],"or":[32],"side":[34],"chains":[35],"substituted":[36],"on":[37],"the":[38,42,67,73,77],"phenyl":[39],"group":[40],"at":[41],"R(3)":[43],"and":[44,58],"R(5)":[45],"positions":[46],"are":[47],"characterized":[48],"by":[49],"high":[51,60],"ROS":[52],"accumulation":[53,78],"capacity":[54],"in":[55],"Candida":[56],"albicans":[57],"activity.":[62],"Moreover,":[63],"could":[65],"link":[66],"mode":[69],"action":[71],"derivatives":[75],"to":[76],"ROS.":[81]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}